Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0001354457-24-000551
Filing Date
2024-08-02
Accepted
2024-08-02 17:01:54
Documents
2
Effectiveness Date
2024-08-02

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1068
2 bcdaw-form25.txt EX-99.25 111
  Complete submission text file 0001354457-24-000551.txt   3251
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Subject) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE | Act: 34 | File No.: 333-230779 | Film No.: 241171969
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address Office of General Counsel 805 King Farm Blvd. ROCKVILLE MD 20850
Business Address One Liberty Plaza New York NY 10006 301-978-4144
Nasdaq Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

EIN.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE